MSTN and Duchenne muscular dystrophy: In addition, inhibition of myostatin in mdx mice significantly attenuated disease severity of muscular dystrophy, suggesting that myostatin may serve as a therapeutic target for the treatment of DMD (Murphy et al., 2010).